Athanor Capital, LP - CHINA BIOLOGIC PRODS HLDGS I ownership

Quarter-by-quarter ownership
Athanor Capital, LP ownership history of CHINA BIOLOGIC PRODS HLDGS I
ValueSharesWeighting
Q1 2021$308,000
-57.7%
2,604
-57.8%
0.01%
-58.8%
Q4 2020$728,000
-61.4%
6,165
-63.7%
0.02%
-76.4%
Q3 2020$1,887,000
+98.8%
16,980
+82.9%
0.07%
+50.0%
Q2 2020$949,0009,2840.05%
Other shareholders
CHINA BIOLOGIC PRODS HLDGS I shareholders Q3 2023
NameSharesValueWeighting ↓
VERNIER CAPITAL PARTNERS, LP 137,557$11,142,0006.62%
COMGEST GLOBAL INVESTORS S.A.S. 637,752$51,658,0001.13%
Black Creek Investment Management Inc. 411,525$33,334,0001.09%
Hillhouse Capital Management 618,391$50,090,0000.88%
RUDMAN ERROL M 21,301$1,725,0000.83%
JUPITER ASSET MANAGEMENT LTD 263,705$21,360,0000.65%
York Capital Management Global Advisors, LLC 341,616$27,671,0000.62%
VONTOBEL ASSET MANAGEMENT INC 873,968$71,525,0000.51%
Temasek Holdings (Private) Ltd 990,000$80,190,0000.44%
WASATCH ADVISORS LP 292,216$23,669,0000.31%
View complete list of CHINA BIOLOGIC PRODS HLDGS I shareholders